TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ACET

Adicet Bio Inc

Healthcare · Biotechnology

6.50$ -2.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACET
Line item 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
94.3% 90.7% 90.3% 67.3% 64.1% 67.5% 59.1% 63.4% 65.2% 98.2% 99.6% 78.7% 65.2% 83.3% 78.9% 78.3% 81.8% 83.7%
22.6% 30.5% 14.2% 9.7% 8.3% 10.3% 9.2% 6.9% 12.4% 96.7% 6.4% 13.0% 54.8% 81.9% 77.9% 77.0% 25.7% 20.2%
22.9% 30.8% 14.4% 10.0% 8.8% 10.9% 9.3% 7.6% 12.5% 96.7% 98.3% 76.5% 61.5% 81.9% 77.9% 77.0% 80.1% 82.4%
– – 34.5% 28.4% 25.0% 27.9% 26.2% 33.0% 31.0% 472.7% – 1.1% 1.8% 0.1% 0.1% – – 0.2%
34.6% 28.7% 34.6% 26.2% 28.3% 25.9% 21.5% 19.5% 18.1% 247.1% – 0.8% -2.0% 1.4% 0.8% – – –
1.0% 1.0% 0.8% 11.4% 11.2% 10.4% 14.2% 13.9% 12.6% 429.3% – – 13.1% 5.7% 5.9% 0.0% – –
2.6% 6.1% 5.7% 17.2% 15.1% 12.6% 18.8% 16.1% 14.6% 516.5% – – 0.8% – – – – –
39.8% 33.8% 42.6% 51.1% 43.9% 39.8% 50.1% 48.1% 43.7% 10.0% 5.2% 174.0% 28.6% 10.6% 11.6% 17.9% 15.3% 17.2%
31.6% 24.8% 34.5% 28.2% 24.6% 27.8% 25.3% 25.5% 18.3% 10.0% 5.2% 18.2% 14.6% 4.8% 6.0% 9.3% 8.8% 11.2%
– – – – 2.2% 3.6% 1.8% 2.1% 0.0% 26.2% – – 0.8% 0.5% 0.8% 1.6% 1.4% 1.7%
21.2% 13.3% 18.5% 15.1% 14.0% 12.1% 10.4% 11.2% 8.5% 2.7% 0.5% 1.3% 1.0% 1.0% 1.3% 1.3% 2.2% 2.5%
68.3% 74.8% 64.5% 54.5% 56.1% 60.2% 49.9% 51.9% 56.3% 90.0% 94.8% -74.0% 71.4% 89.4% 88.4% 82.1% 84.7% 82.8%
39.8% 45.1% 40.2% 30.8% 34.2% 36.7% 30.1% 34.1% 36.0% -61.2% -64.9% -85.4% -69.1% -49.7% -72.0% -183.7% -226.1% -319.6%
0.7% 0.7% 0.6% 0.5% 0.5% 0.5% 0.3% 0.3% 0.3% 3.1% 1.7% 1.4% 0.3% 0.6% 0.8% 1.3% 2.5% 3.6%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?